# Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid

> **NCT03262246** · — · COMPLETED · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 126 (actual)

## Conditions studied

- Amyloid Angiopathy

## Interventions

- **OTHER:** medical report consultation

## Key facts

- **NCT ID:** NCT03262246
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-02
- **Primary completion:** 2016-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262246, "Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03262246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*